Patients with axSpA who received UPA reported rapid and sustained improvements in total and nocturnal back pain over 12 weeks.

ReGelTec Inc., a company developing a percutaneous hydrogel implant for the treatment of chronic low back pain caused by ...

Chronic pain in India linked to suicide risk, overlooked in mental health assessments, highlighting need for integrated care.

A single 25 mg dose of psilocybin, paired with psychological support, brought lasting relief from depression and anxiety in ...

Fremanezumab vs placebo significantly reduced monthly migraine days and depressive symptoms in patients with migraine and comorbid major depressive disorder.

Both dyspnea and respiratory drive went down with vs. without nasal high-flow therapy in orally intubated patients, according ...

A study published by researchers at University Hospitals Connor Whole Health and Case Western Reserve University School of ...

High-dose dazucorilant patients who went into the open-label extension saw an 84% lower risk of death over those who didn't ...

Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbosacral radiculopathy (LSR), a form of neuropathic back pain, ahead of an FDA ...

CyberArk (CYBR) is buy rated as growth accelerates with soaring ARR, strategic acquisitions, and increasing demand for ...

Allegheny County Public Works says that, during the Rachel Carson Bridge’s last inspection in 2023, inspectors gave the ...

Some parts of the U.S., such as Phoenix, Arizona, are famously hot without the mugginess. Phoenix and nearby desert regions ...